Insulet Corp: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Insulet Corp Unternehmen

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

Unternehmensinformationen

BörsenkürzelPODD

Name des UnternehmensInsulet Corp

IPO-datumMay 15, 2007

Gegründet am2000

CEOMs. Ashley Mcevoy

Anzahl der mitarbeiter3900

WertpapierartOrdinary Share

GeschäftsjahresendeMay 15

Addresse100 Nagog Park

StadtACTON

BörseNASDAQ Global Select Consolidated

LandUnited States of America

Postleitzahl01720-3440

Telefon19786007000

Websitehttps://www.omnipod.com

BörsenkürzelPODD

IPO-datumMay 15, 2007

Gegründet am2000

Führungskräfte

Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. Jessica Hopfield, Ph.D.

Independent Director

27.70K

+2.89%

Mr. Michael R. Minogue

Independent Director

16.23K

+5.03%

Mr. Eric Benjamin

Executive Vice President, Chief Product and Customer Experience Officer

14.73K

--

Ms. Ashley Mcevoy

President, Chief Executive Officer, Director

9.54K

+238.50K%

Mr. Prem Singh

Senior Vice President - Global Operations

5.32K

+50.42%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

5.24K

+17.43%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Corporate Controller

5.22K

+17.01%

Ms. Laetitia Cousin

Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance

3.58K

+24.38%

Dr. Luciana Borio, M.D.

Independent Director

3.09K

-13.48%

Mr. Timothy C. (Tim) Stonesifer

Independent Director

2.89K

+36.78%

Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. Jessica Hopfield, Ph.D.

Independent Director

27.70K

+2.89%

Mr. Michael R. Minogue

Independent Director

16.23K

+5.03%

Mr. Eric Benjamin

Executive Vice President, Chief Product and Customer Experience Officer

14.73K

--

Ms. Ashley Mcevoy

President, Chief Executive Officer, Director

9.54K

+238.50K%

Mr. Prem Singh

Senior Vice President - Global Operations

5.32K

+50.42%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

5.24K

+17.43%

Umsatzaufteilung

Währung: USDAktualisiert: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

U.S.Omnipod

1.51B

72.86%

International Omnipod

523.40M

25.27%

Drug Delivery

38.90M

1.88%

Nach RegionUSD

Name

Umsatz

Anteil

United States

1.55B

74.73%

All Other

523.40M

25.27%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

U.S.Omnipod

1.51B

72.86%

International Omnipod

523.40M

25.27%

Drug Delivery

38.90M

1.88%

Aktionärsstatistik

Aktualisiert: Fri, May 16

Aktionäre

Aktionärstypen

Aktionäre

Anteil

The Vanguard Group, Inc.

12.28%

Fidelity Management & Research Company LLC

10.13%

Capital Research Global Investors

8.64%

BlackRock Institutional Trust Company, N.A.

6.20%

State Street Global Advisors (US)

4.30%

Other

58.46%

Aktionäre

Anteil

The Vanguard Group, Inc.

12.28%

Fidelity Management & Research Company LLC

10.13%

Capital Research Global Investors

8.64%

BlackRock Institutional Trust Company, N.A.

6.20%

State Street Global Advisors (US)

4.30%

Other

58.46%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

55.57%

Investment Advisor/Hedge Fund

36.05%

Hedge Fund

3.40%

Research Firm

2.90%

Pension Fund

1.66%

Sovereign Wealth Fund

1.45%

Bank and Trust

1.38%

Individual Investor

0.29%

Private Equity

0.10%

Institutionelle Beteiligung

Aktualisiert: Mon, Jan 20

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q1

1519

73.36M

104.26%

-4.82M

2024Q4

1508

72.57M

103.34%

-4.94M

2024Q3

1436

73.14M

104.31%

-3.15M

2024Q2

1408

72.17M

103.04%

-3.02M

2024Q1

1350

71.60M

102.26%

-3.12M

2023Q4

1320

72.91M

104.42%

-1.52M

2023Q3

1254

72.05M

103.19%

-4.06M

2023Q2

1223

73.42M

105.35%

-3.44M

2023Q1

1206

74.71M

107.20%

-300.49K

2022Q4

1126

71.74M

103.30%

-3.89M

Aktionärsaktivitäten

Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

The Vanguard Group, Inc.

8.46M

12.05%

+16.65K

+0.20%

Dec 31, 2024

Fidelity Management & Research Company LLC

7.08M

10.08%

-246.09K

-3.36%

Dec 31, 2024

Capital Research Global Investors

7.45M

10.6%

-326.10K

-4.20%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

4.25M

6.05%

+74.08K

+1.77%

Dec 31, 2024

State Street Global Advisors (US)

2.97M

4.24%

+59.55K

+2.04%

Dec 31, 2024

Baillie Gifford & Co.

2.36M

3.35%

+79.98K

+3.51%

Dec 31, 2024

Geode Capital Management, L.L.C.

1.78M

2.53%

+40.57K

+2.33%

Dec 31, 2024

ClearBridge Investments, LLC

1.41M

2%

-62.73K

-4.27%

Dec 31, 2024

Fidelity International

1.43M

2.04%

-9.70K

-0.67%

Dec 31, 2024

American Century Investment Management, Inc.

854.87K

1.22%

-3.60K

-0.42%

Dec 31, 2024

Verbundene ETFs

Aktualisiert: Fri, Jun 6

Name

Anteil

Langar Global HealthTech ETF

9.36%

Global X HealthTech ETF

5.38%

Fidelity Digital Health ETF

5.13%

Goldman Sachs Future Health Care Equity ETF

4.13%

First Trust Nasdaq Lux Digi Health Solutions ETF

4.06%

Nuveen ESG Mid-Cap Growth ETF

3.55%

Congress SMid Growth ETF

2.83%

First Trust Health Care Alphadex Fund

2.81%

iShares U.S. Medical Devices ETF

2.75%

iShares Health Innovation Active ETF

2.73%

Langar Global HealthTech ETF

Anteil9.36%

Global X HealthTech ETF

Anteil5.38%

Fidelity Digital Health ETF

Anteil5.13%

Goldman Sachs Future Health Care Equity ETF

Anteil4.13%

First Trust Nasdaq Lux Digi Health Solutions ETF

Anteil4.06%

Nuveen ESG Mid-Cap Growth ETF

Anteil3.55%

Congress SMid Growth ETF

Anteil2.83%

First Trust Health Care Alphadex Fund

Anteil2.81%

iShares U.S. Medical Devices ETF

Anteil2.75%

iShares Health Innovation Active ETF

Anteil2.73%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split

Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten

Insulet Corp

308.534USD

Insulet Corp

308.534

Übersicht

Unternehmen